Assessment of bioequivalence after subcutaneous and intramuscular administration of urinary gonadotrophins
article
The objective was to demonstrate bioequivalence between s.c. and i.m. administration of Humegon® (FSH/LH ratio 1:1) and Normegon® (FSH/LH ratio 3:1). In two randomized, single-centre, cross-over studies, 18 healthy volunteers on each formulation were assigned to one of the two administration sequences. Subjects were given single doses of one of the above gonadotrophins after endogenous gonadotrophin production had first been suppressed using high-dose oral contraceptive, Subsequently, rate (C(max), t(max)) and extent (AUC) of absorption of follicle stimulating hormone (FSH) and luteinizing hormone (LH) were determined for 14 days, For C(max) and AUC, analysis of variance (ANOVA) was performed on log-transformed data and for t(max) ANOVA was performed on ranks. Intramuscular and s.c. injections of Humegon were bioequivalent with respect to the main pharmacokinetic parameters, being AUC and C(max) of FSH absorption. Intramuscular and s.c. injections of Normegon were bioequivalent with respect to the AUC of FSH and not bioequivalent with respect to the C(max) of FSH. For t(max) of FSH as well as for most LH variables of both preparations, bioequivalence could not be be proven due to the high intra- and interindividual variability and/or concentrations being close to the detection limit. Thus, the main pharmacokinetic FSH variables after i.m. and s.c. administration of Humegon and Normegon were bioequivalent.
Topics
BioequivalenceFSHHuman menopausal gonadotrophinIntramuscularLHSubcutaneousFollitropinHuman menopausal gonadotropinLuteinizing hormoneUnclassified drugAdultArea under the curveBioequivalenceClinical trialControlled clinical trialControlled studyCrossover procedureDrug blood levelFemaleFollitropin blood levelHumanHuman experimentIntramuscular drug administrationLuteinizing hormone blood levelNormal humanRandomized controlled trialSubcutaneous drug administrationAbsorptionAdolescentAdultCross-Over StudiesFemaleFollicle Stimulating HormoneHumansInjections, IntramuscularInjections, SubcutaneousLuteinizing HormoneMenotropinsTherapeutic Equivalency
TNO Identifier
233744
ISSN
02681161
Source
Human Reproduction, 12(1), pp. 34-38.
Pages
34-38
Files
To receive the publication files, please send an e-mail request to TNO Repository.